Chesyl Pharma

Learn lessons from the success stories of five UK pharmaceutical companies—Acambis, Celltech, Galen, Powderjet, and Shire—to assist a select group of emerging pharmaceutical companies in preparing for a successful initial public offering (IPO), and more importantly, in maintaining success after becoming publicly listed. As a key statement, risk management is considered the most crucial factor for a sustainable and successful strategy in pharmaceutical and R&D companies.